Taste loss in COVID-19-psychophysical evidence supporting a low prevalence

Publikation: Beitrag in FachzeitschriftKurzartikel (Letter) / Leserbrief mit OriginaldatenBeigetragenBegutachtung

Beitragende

  • CA Hintschich - , Universitätsklinikum Regensburg (Autor:in)
  • S Le Bon - , Hôpitaux universitaires de Genève, CHU Saint-Pierre University Hospital (Autor:in)
  • E Trecca - , University Hospital of Foggia, IRCCS Ospedale Casa Sollievo della Sofferenza - San Giovanni Rotondo (FG) (Autor:in)
  • S Saussez - , Universite de Mons (Autor:in)
  • T Hummel - , Klinik und Poliklinik für Hals-Nasen-Ohrenheilkunde (Autor:in)

Abstract

Much - possibly even too much - has been published about chemosensory dysfunction as a consequence of COVID-19. Studies have reported prevalence of taste loss in up to 89.9%, which is in a similar range as COVID-19 related smell loss. However, most of these publications rely solely on patients' self-reports. Only few studies used validated psychophysical tests to specifically address olfaction and gustation. Especially for gustation, it is evident that subjective reporting does not correlate well with more objective psychophysical findings, often leading to an overestimation of subjectively impaired taste.

Details

OriginalspracheEnglisch
Seiten (von - bis)511-512
Seitenumfang2
FachzeitschriftRhinology
Jahrgang62
Ausgabenummer4
PublikationsstatusVeröffentlicht - 1 Aug. 2024
Peer-Review-StatusJa

Externe IDs

PubMed 38530198
Scopus 85200622879
ORCID /0000-0001-9713-0183/work/165878210

Schlagworte